This suggests the role of IL-23 in contributing to the increase in Th17/IL-17 seen in premalignant oral lesions and the decline in IL-23 in the reduced levels of Th17/IL-17 in the HNSCC milieu. Here, IL17A is linked to head and neck squamous cell carcinoma.